Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Assets (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Other Non-Current Assets for 3 consecutive years, with $458000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 71.54% year-over-year to $458000.0; the TTM value through Dec 2025 reached $458000.0, up 71.54%, while the annual FY2025 figure was $458000.0, 71.54% up from the prior year.
  • Other Non-Current Assets hit $458000.0 in Q4 2025 for Artiva Biotherapeutics, down from $461000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $461000.0 in Q2 2025 and bottomed at $13000.0 in Q1 2025.
  • Average Other Non-Current Assets over 3 years is $291636.4, with a median of $258000.0 recorded in 2023.
  • On a YoY basis, Other Non-Current Assets climbed as much as 78.68% in 2025 and fell as far as 94.96% in 2025.
  • Artiva Biotherapeutics' Other Non-Current Assets stood at $258000.0 in 2023, then grew by 3.49% to $267000.0 in 2024, then soared by 71.54% to $458000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $458000.0, $461000.0, and $461000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.